Latest Period
Q2 2026
Security Snapshot
CORCEPT THERAPEUTICS INC - COMMON STOCK (CORT) Institutional Ownership
CUSIP: 218352102
13F Institutional Holders and Ownership History from Q1 2014 to Q2 2026
Institutions Reporting
187
Shares (Excl. Options)
25,668,973
Price
$86.95
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / COMMON STOCK
- Symbol
- CORT on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 25,668,973
- Total 13F value
- $2,232,077,632
- Portfolio coverage rank
- 0%
- Share change
- +1,653,269
- Value change
- +$154,813,245
- Number of holders
- 187
- Shares outstanding
- 106,815,676
- SEC-reported price per share
- $91.61
- Insider filing price
- $91.61
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- CORT - CORCEPT THERAPEUTICS INC - COMMON STOCK is tracked under CUSIP 218352102.
- 187 institutions reported positions in Q2 2026.
- 4 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 348 to 187 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $3,201,576,900 to $2,232,077,632.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 187 institutions filings for Q2 2026.
Security key
218352102
Latest holder period
Q2 2026
13F holders
187
13D/G owners
4
CIK / CUSIP context first
Open Q2 2026 holders
CORT full holder history
CORCEPT THERAPEUTICS INC SEC filings
CORCEPT THERAPEUTICS INC company facts
CORCEPT THERAPEUTICS INC insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 218352102:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
4
Security
CORT
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 11% | -14% | $846,969,867 | -$132,857,230 | 11,539,099 | -14% | BlackRock, Inc. | 30 Jun 2025 |
| INGALLS & SNYDER LLC | 6.8% | -12% | $292,790,314 | -$36,692,379 | 7,263,466 | -11% | INGALLS & SNYDER LLC | 31 Dec 2025 |
| BELANOFF JOSEPH K | 6.3% | $499,599,592 | 6,822,335 | Joseph K. Belanoff | 31 Dec 2024 | |||
| RENAISSANCE TECHNOLOGIES LLC | 5.5% | $200,396,774 | 5,758,528 | Renaissance Technologies LLC | 31 Dec 2025 |
As of 30 Jun 2026, 187 institutional investors reported holding 25,668,973 shares of CORCEPT THERAPEUTICS INC - COMMON STOCK (CORT). This represents 24% of the company’s total 106,815,676 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
23%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 12% | 12,432,023 | +2.3% | 0.02% | $1,080,964,444 |
| Parallel Advisors, LLC | 3.7% | 3,962,177 | -0.38% | 5.3% | $344,511,290 |
| STATE STREET CORP | 3.1% | 3,279,381 | +2.5% | 0.01% | $285,150,433 |
| EMERALD ADVISERS, LLC | 0.7% | 748,325 | +264% | 1.5% | $65,066,859 |
| Bank of New York Mellon Corp | 0.53% | 565,666 | +4% | 0.01% | $49,184,686 |
| EMERALD MUTUAL FUND ADVISERS TRUST | 0.44% | 464,902 | +159% | 1.4% | $40,423,229 |
| PRINCIPAL FINANCIAL GROUP INC | 0.43% | 459,742 | +0.99% | 0.02% | $39,974,567 |
| Boston Trust Walden Corp | 0.41% | 440,264 | -4.8% | 0.29% | $38,280,954 |
| FAS Wealth Partners, Inc. | 0.3% | 324,876 | +0.78% | 1.5% | $28,247,969 |
| Russell Investments Group, Ltd. | 0.17% | 178,167 | +1257% | 0.01% | $15,491,721 |
| Granite Investment Partners, LLC | 0.16% | 172,228 | 0.77% | $14,975,225 | |
| CITIGROUP INC | 0.13% | 141,809 | -66% | 0.01% | $12,330,293 |
| LPL Financial LLC | 0.13% | 139,389 | +3.8% | 0% | $12,119,874 |
| Alberta Investment Management Corp | 0.11% | 113,200 | 0.06% | $9,842,740 | |
| Walleye Capital LLC | 0.09% | 99,847 | +9885% | 0.04% | $8,681,697 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.09% | 98,803 | +52% | 0.01% | $8,590,921 |
| KBC Group NV | 0.09% | 91,584 | -3.4% | 0.02% | $7,963,000 |
| F/m Investments LLC | 0.08% | 88,042 | +72% | 0.39% | $7,655,252 |
| NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 0.08% | 85,579 | -17% | 0.01% | $7,441,000 |
| BROWN CAPITAL MANAGEMENT LLC | 0.08% | 84,041 | -10% | 1.5% | $7,307,365 |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 0.08% | 83,110 | 0.15% | $7,226,414 | |
| ENVESTNET ASSET MANAGEMENT INC | 0.07% | 76,626 | +83% | 0% | $6,662,590 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 0.07% | 76,278 | 0.01% | $6,648,944 | |
| Stanley-Laman Group, Ltd. | 0.06% | 68,196 | -0.63% | 0.6% | $5,929,642 |
| FIFTH THIRD BANCORP | 0.05% | 51,914 | +39% | 0.01% | $4,513,940 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
50
Latest
Q2 2026
Rows shown
1-25 of 50
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 25,668,973 | $2,232,077,632 | +$154,813,245 | $86.95 | 187 |
| 2026 Q1 | 79,443,668 | $3,201,576,900 | +$152,593,478 | $40.31 | 348 |
| 2025 Q4 | 76,610,607 | $2,668,599,587 | -$117,770,292 | $34.80 | 384 |
| 2025 Q3 | 77,152,974 | $6,407,786,320 | -$135,227,246 | $83.11 | 424 |
| 2025 Q2 | 78,953,366 | $5,792,808,674 | -$256,092,991 | $73.40 | 418 |
| 2025 Q1 | 81,954,269 | $9,118,688,561 | -$126,808,558 | $114.22 | 408 |
| 2024 Q4 | 84,197,994 | $4,242,065,667 | -$207,314,469 | $50.39 | 362 |
| 2024 Q3 | 88,403,089 | $4,090,692,212 | +$3,394,284 | $46.28 | 316 |
| 2024 Q2 | 89,225,655 | $2,899,048,485 | -$128,567,810 | $32.49 | 282 |
| 2024 Q1 | 93,600,393 | $2,357,405,516 | +$206,853,940 | $25.19 | 283 |
| 2023 Q4 | 84,732,406 | $2,752,093,285 | +$61,774,959 | $32.48 | 269 |
| 2023 Q3 | 83,019,792 | $2,261,938,980 | +$53,168,814 | $27.24 | 244 |
| 2023 Q2 | 81,489,147 | $1,813,024,077 | -$128,901,748 | $22.25 | 224 |
| 2023 Q1 | 87,299,563 | $1,890,881,420 | +$97,037,592 | $21.66 | 231 |
| 2022 Q4 | 83,493,481 | $1,696,055,001 | -$86,283,839 | $20.31 | 241 |
| 2022 Q3 | 87,114,680 | $2,234,275,240 | +$46,310,026 | $25.64 | 225 |
| 2022 Q2 | 85,057,351 | $2,023,773,420 | +$98,901,040 | $23.78 | 214 |
| 2022 Q1 | 81,373,846 | $1,836,938,219 | +$19,570,522 | $22.52 | 214 |
| 2021 Q4 | 80,562,329 | $1,594,701,243 | -$8,205,377 | $19.80 | 199 |
| 2021 Q3 | 80,869,592 | $1,591,453,895 | +$4,936,347 | $19.68 | 193 |
| 2021 Q2 | 80,507,190 | $1,769,402,198 | -$27,080,717 | $22.00 | 193 |
| 2021 Q1 | 81,631,723 | $1,941,273,564 | -$37,899,526 | $23.79 | 205 |
| 2020 Q4 | 83,389,910 | $2,180,799,586 | -$129,685,932 | $26.16 | 219 |
| 2020 Q3 | 89,228,523 | $1,552,636,140 | +$5,152,396 | $17.40 | 215 |
| 2020 Q2 | 89,585,381 | $1,506,658,948 | +$28,288,519 | $16.82 | 215 |